person · Reporting owner

RYAN THOMAS M

Disclosed activity across 5 companies

Tapewire entity: 13285
SEC CIK: 0001194416

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
BANK OF AMERICA CORP /DE/BAC · Entity 2801	Director	April 29, 2009	May 01, 2009
CVS HEALTH CorpCVS · Entity 2884	Director · Non-Executive Chairman	April 03, 2011	April 05, 2011
FIVE BELOW, INCFIVE · Entity 3393	Director	May 04, 2026	May 06, 2026
PJT Partners Inc.PJT · Entity 3655	Director	September 16, 2026	September 18, 2026
YUM BRANDS INCYUM · Entity 3067	Director	February 10, 2017	February 13, 2017

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BANK OF AMERICA CORP /DE/

Report date April 29, 2009 · Filed May 01, 2009

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Director Stock Unit PlanSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	27,616.64	Reported balance After 2009-03-27 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2009-03-27 · Grant · Acquired 37.58 · Balance 27,616.64 F1: Reinvested Director Deferred Compensation and Stock Unit Plan dividend Equivalents. Director Deferred Compensation and Stock Unit Plan units may be settled in stock upon death or termination of service as a director. F2: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director.
Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	31,130.07	Reported balance After 2009-03-27 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2009-03-27 · Grant · Acquired 42.36 · Balance 31,130.07 F3: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. F2: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. F4: Phantom stock units may be settled in cash upon death or termination of service as a director.
Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	49,563.25	Reported balance After 2009-04-29 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2009-04-29 · Grant · Acquired 18,433.18 · Balance 49,563.25 F5: Stock units represent payment of the restricted stock portion of the annual Directors' compensation under the Bank of America Corporation Directors' Stock Plan in transactions exempt under Rule 16b-3. F4: Phantom stock units may be settled in cash upon death or termination of service as a director.
Common StockSEC Table I · non-derivative	Direct	57,260	Reported balance Holding disclosure · report date 2009-04-29 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 57,260
Common StockSEC Table I · non-derivative	Indirectby Ryan Family Foundation	1,175	Reported balance Holding disclosure · report date 2009-04-29 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 1,175
Common StockSEC Table I · non-derivative	IndirectBy Spouse Trust	804	Reported balance Holding disclosure · report date 2009-04-29 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 804

Filing footnotes · ownership attribution and instrument terms

F1: Reinvested Director Deferred Compensation and Stock Unit Plan dividend Equivalents. Director Deferred Compensation and Stock Unit Plan units may be settled in stock upon death or termination of service as a director.

F2: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director.

F3: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director.

F4: Phantom stock units may be settled in cash upon death or termination of service as a director.

F5: Stock units represent payment of the restricted stock portion of the annual Directors' compensation under the Bank of America Corporation Directors' Stock Plan in transactions exempt under Rule 16b-3.

CVS HEALTH Corp

Report date April 03, 2011 · Filed April 05, 2011

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Trust As Beneficiary	505,743	Reported balance After 2011-01-07 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2011-01-07 · Gift · Disposed 11,150 · Balance 505,743
Common StockSEC Table I · non-derivative	Direct	1,156,701.9341	Reported balance After 2011-04-03 transaction · row 2 1 source row Row 2 · 2011-04-03 · Tax withholding · Disposed 27,468 · Balance 1,156,701.9341 F1: Surrender of shares in payment of withholding taxes due.
Common StockSEC Table I · non-derivative	IndirectBy Foundation	67,040	Reported balance Holding disclosure · report date 2011-04-03 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 67,040
Common Stock (restricted)SEC Table I · non-derivative	Direct	481,337.4102	Reported balance Holding disclosure · report date 2011-04-03 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 481,337.4102
ESOP Common StockSEC Table I · non-derivative	IndirectBy ESOP	8,322.4199	Reported balance Holding disclosure · report date 2011-04-03 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 8,322.4199
Stock UnitSEC Table I · non-derivative	Direct	1,086,391.5831	Reported balance Holding disclosure · report date 2011-04-03 · row 6 Holding and transaction disclosures are not merged. 1 source row Row 6 · Balance 1,086,391.5831

Filing footnotes · ownership attribution and instrument terms

F1: Surrender of shares in payment of withholding taxes due.

FIVE BELOW, INC

Report date May 04, 2026 · Filed May 06, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	119,030	Reported balance After 2026-05-04 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2026-05-04 · Grant · Acquired 96 · Balance 119,030 F1: The shares were issued to the reporting person pursuant to the Five Below, Inc. Compensation Policy for Non-Employee Directors in lieu of a quarterly retainer payment of $22,500.00, less applicable tax withholdings. F2: Includes shares held by the reporting person's revocable trust.

Filing footnotes · ownership attribution and instrument terms

F1: The shares were issued to the reporting person pursuant to the Five Below, Inc. Compensation Policy for Non-Employee Directors in lieu of a quarterly retainer payment of $22,500.00, less applicable tax withholdings.

F2: Includes shares held by the reporting person's revocable trust.

PJT Partners Inc.

Report date September 16, 2026 · Filed September 18, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	11,940	Reported balance After 2026-09-16 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-09-16 · Grant · Acquired 19 · Balance 11,940 F1: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F2: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock.

F2: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units.

YUM BRANDS INC

Report date February 10, 2017 · Filed February 13, 2017

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	3,749	Reported balance After 2017-02-10 transaction · row 1 1 source row Row 1 · 2017-02-10 · Grant · Acquired 3,749 · Balance 3,749
Common StockSEC Table I · non-derivative	IndirectRyan Trust	38,706	Reported balance Holding disclosure · report date 2017-02-10 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 38,706

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
December 08, 2006 Filed Dec 8, 2006 21:49 UTC	CVS HEALTH Corp CVS · Entity 2884	Exercise / conversionCommon Stock	78,264	$11.50	$900,036.00	Disclosure SEC source: 0000064803-06-000045 · doc.xml · nonDerivative · entry 5 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
December 07, 2006 Filed Dec 8, 2006 21:49 UTC	CVS HEALTH Corp CVS · Entity 2884	Exercise / conversionStock Option · Derivative	78,264	$0.00 Strike: $11.50	$0.00	Disclosure SEC source: 0000064803-06-000045 · doc.xml · derivative · entry 10 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 626,112 Underlying: Common Stock · 78,264 shares Expires 2007-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 02/17/00. Read SEC document
December 07, 2006 Filed Dec 8, 2006 21:49 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	52,200	$30.14	$1,573,161.84	Disclosure SEC source: 0000064803-06-000045 · doc.xml · nonDerivative · entry 4 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,934 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $29.98 and $30.48 per share. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
December 07, 2006 Filed Dec 8, 2006 21:49 UTC	CVS HEALTH Corp CVS · Entity 2884	Exercise / conversionCommon Stock	78,264	$11.50	$900,036.00	Disclosure SEC source: 0000064803-06-000045 · doc.xml · nonDerivative · entry 3 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
December 06, 2006 Filed Dec 8, 2006 21:49 UTC	CVS HEALTH Corp CVS · Entity 2884	Exercise / conversionStock Option · Derivative	78,264	$0.00 Strike: $11.50	$0.00	Disclosure SEC source: 0000064803-06-000045 · doc.xml · derivative · entry 9 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 704,376 Underlying: Common Stock · 78,264 shares Expires 2007-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 02/17/00. Read SEC document
December 06, 2006 Filed Dec 8, 2006 21:49 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	52,200	$30.18	$1,575,406.44	Disclosure SEC source: 0000064803-06-000045 · doc.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,870 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $29.66 and $30.52 per share. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
December 06, 2006 Filed Dec 8, 2006 21:49 UTC	CVS HEALTH Corp CVS · Entity 2884	Exercise / conversionCommon Stock	78,264	$11.50	$900,036.00	Disclosure SEC source: 0000064803-06-000045 · doc.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
April 26, 2006 Filed Apr 28, 2006 13:56 UTC	BANK OF AMERICA CORP /DE/ BAC · Entity 2801	GrantPhantom Stock · Derivative	5,449.59	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-06-002312 · doc4.xml · derivative · entry 4 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,098.57 Underlying: Common Stock · 5,449.59 shares Expires not disclosed F1 · shares: Shares represent payment of the annual Directors' compensation under the Bank of America Corporation Directors' Stock Plan in transactions exempt under Rule 16b-3. F2 · derivative.exercise_date: Phantom stock units may be settled in cash upon death or termination of service as a director. F2 · derivative.expiration_date: Phantom stock units may be settled in cash upon death or termination of service as a director. F3 · balance_after: Includes 401.96 phantom stock units acquired between June 24, 2005 and March 24, 2006 with reinvested dividend equivalents under the Bank of America Director Stock Plan. Read SEC document
April 03, 2006 Filed Apr 5, 2006 20:22 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantStock Option · Derivative	491,761	$0.00 Strike: $30.04	$0.00	Disclosure SEC source: 0001194405-06-000013 · doc.xml · derivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 491,761 Underlying: Common Stock · 491,761 shares Expires 2013-04-03 F1 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/3/07 Read SEC document
April 03, 2006 Filed Apr 5, 2006 20:22 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantCommon Stock (Restricted)	133,177	$0.00	$0.00	Disclosure SEC source: 0001194405-06-000013 · doc.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 933,177 Read SEC document
February 16, 2006 Filed Feb 21, 2006 21:40 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantStock Unit	58,850	$0.00	$0.00	Disclosure SEC source: 0001194405-06-000005 · doc.xml · nonDerivative · entry 3 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 458,850 F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receirpt of which the reporting person has elected to defer. Read SEC document
January 01, 2006 Filed Jan 4, 2006 20:06 UTC	BANK OF AMERICA CORP /DE/ BAC · Entity 2801	GrantCommon Stock	250	$0.00	$0.00	Disclosure SEC source: 0001225208-06-000152 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Trust Disclosed balance after: 250 F1 · kind: Received in exchange for common stock of MBNA Corporation at an exchange rate of .5009 of a share of Bank of America and $4.125 in cash for each share of MBNA Corporation in connection with the merger of MBNA into Bank of America on January 1, 2006. On last business day preceding the effective date of the merger, the closing price of MBNA's common stock was $27.15 per share, and the closing price of Bank of America's common stock was $46.15 per share. F1 · price: Received in exchange for common stock of MBNA Corporation at an exchange rate of .5009 of a share of Bank of America and $4.125 in cash for each share of MBNA Corporation in connection with the merger of MBNA into Bank of America on January 1, 2006. On last business day preceding the effective date of the merger, the closing price of MBNA's common stock was $27.15 per share, and the closing price of Bank of America's common stock was $46.15 per share. Read SEC document
August 05, 2005 Filed Aug 9, 2005 19:26 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantCommon Stock (Restricted)	400,000	$0.00	$0.00	Disclosure SEC source: 0001194416-05-000005 · doc.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 882,440 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on 12/31/2009. Read SEC document
May 18, 2005 Filed May 19, 2005 17:57 UTC	BANK OF AMERICA CORP /DE/ BAC · Entity 2801	PurchaseCommon Stock	1,000	$46.60	$46,600.00	Disclosure SEC source: 0000070858-05-000267 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,260 Read SEC document
May 17, 2005 Filed May 19, 2005 20:26 UTC	CVS HEALTH Corp CVS · Entity 2884	Exercise / conversionStock Option · Derivative	192,920	$0.00 Strike: $16.72	$0.00	Disclosure SEC source: 0001194416-05-000003 · c0001194416d20050519f4f.xml · derivative · entry 6 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 192,920 shares Expires 2006-04-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 17, 2005 Filed May 19, 2005 20:26 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	192,920	$54.33	$10,481,227.85	Disclosure SEC source: 0001194416-05-000003 · c0001194416d20050519f4f.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,462 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 17, 2005 Filed May 19, 2005 20:26 UTC	CVS HEALTH Corp CVS · Entity 2884	Exercise / conversionCommon Stock	192,920	$16.72	$3,226,066.12	Disclosure SEC source: 0001194416-05-000003 · c0001194416d20050519f4f.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
April 27, 2005 Filed Apr 28, 2005 21:05 UTC	BANK OF AMERICA CORP /DE/ BAC · Entity 2801	GrantPhantom Stock · Derivative	4,468.46	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0000070858-05-000234 · doc4.xml · derivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,247.02 Underlying: Common Stock · 4,468.46 shares Expires not disclosed F1 · kind: Shares represent payment of the annual retainer fee and an additional award of restricted shares under the Bank of America Corpor ation Directors' Stock Plan in transactions exempt under Rule 16b-3. F2 · price: Phantom stock units may be settled in cash upon death or termination of service as a director. F2 · derivative.exercise_date: Phantom stock units may be settled in cash upon death or termination of service as a director. F2 · derivative.expiration_date: Phantom stock units may be settled in cash upon death or termination of service as a director. Read SEC document
February 15, 2005 Filed Feb 17, 2005 21:32 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantCommon Stock	34,084	$0.00	$0.00	Disclosure SEC source: 0001194414-05-000002 · c0001194416d20050217f4f.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust as beneficiary Disclosed balance after: 519,724 F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document
January 05, 2005 Filed Jan 7, 2005 21:52 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantStock Option · Derivative	200,000	$0.00 Strike: $44.89	$0.00	Disclosure SEC source: 0001194416-05-000001 · c0001194416d20050107f4f.xml · derivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2012-01-05 F1 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 01/05/2006. Read SEC document
January 05, 2005 Filed Jan 7, 2005 21:52 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantCommon Stock (Restricted)	125,000	$0.00	$0.00	Disclosure SEC source: 0001194416-05-000001 · c0001194416d20050107f4f.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,711 Read SEC document
May 26, 2004 Filed May 27, 2004 20:13 UTC	BANK OF AMERICA CORP /DE/ BAC · Entity 2801	GrantPhantom Stock · Derivative	2,296.84	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0000070858-04-000309 · doc4.xml · derivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,296.84 Underlying: Common Stock · 2,296.84 shares Expires not disclosed F1 · kind: Shares represent payment of the annual retainer fee and an additional award of restricted shares under the Bank of America Corpor ation Directors' Stock Plan in transactions exempt under Rule 16b-3. F2 · price: Phantom stock units may be settled in cash upon death or termination of service as a director. F2 · derivative.exercise_date: Phantom stock units may be settled in cash upon death or termination of service as a director. F2 · derivative.expiration_date: Phantom stock units may be settled in cash upon death or termination of service as a director. Read SEC document
May 19, 2004 Filed May 19, 2004 22:15 UTC	CVS HEALTH Corp CVS · Entity 2884	Exercise / conversionStock Option · Derivative	197,100	$0.00 Strike: $16.72	$0.00	Disclosure SEC source: 0001194416-04-000009 · c0001194416d20040519f4f.xml · derivative · entry 23 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,920 Underlying: Common Stock · 197,100 shares Expires 2006-04-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 19, 2004 Filed May 19, 2004 22:15 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	7,800	$40.25	$313,950.00	Disclosure SEC source: 0001194416-04-000009 · c0001194416d20040519f4f.xml · nonDerivative · entry 17 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,127 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed May 19, 2004 22:15 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	4,600	$40.24	$185,104.00	Disclosure SEC source: 0001194416-04-000009 · c0001194416d20040519f4f.xml · nonDerivative · entry 16 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,927 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed May 19, 2004 22:15 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	6,600	$40.23	$265,518.00	Disclosure SEC source: 0001194416-04-000009 · c0001194416d20040519f4f.xml · nonDerivative · entry 15 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,527 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed May 19, 2004 22:15 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	5,800	$40.22	$233,276.00	Disclosure SEC source: 0001194416-04-000009 · c0001194416d20040519f4f.xml · nonDerivative · entry 14 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,127 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed May 19, 2004 22:15 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	500	$40.21	$20,105.00	Disclosure SEC source: 0001194416-04-000009 · c0001194416d20040519f4f.xml · nonDerivative · entry 13 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,927 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed May 19, 2004 22:15 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	4,600	$40.20	$184,920.00	Disclosure SEC source: 0001194416-04-000009 · c0001194416d20040519f4f.xml · nonDerivative · entry 12 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,427 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed May 19, 2004 22:15 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	5,700	$40.19	$229,083.00	Disclosure SEC source: 0001194416-04-000009 · c0001194416d20040519f4f.xml · nonDerivative · entry 11 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,027 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed May 19, 2004 22:15 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	25,700	$40.18	$1,032,626.00	Disclosure SEC source: 0001194416-04-000009 · c0001194416d20040519f4f.xml · nonDerivative · entry 10 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,727 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed May 19, 2004 22:15 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	52,600	$40.17	$2,112,942.00	Disclosure SEC source: 0001194416-04-000009 · c0001194416d20040519f4f.xml · nonDerivative · entry 9 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,427 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed May 19, 2004 22:15 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	42,800	$40.16	$1,718,848.00	Disclosure SEC source: 0001194416-04-000009 · c0001194416d20040519f4f.xml · nonDerivative · entry 8 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,027 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed May 19, 2004 22:15 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	40,400	$40.15	$1,622,060.00	Disclosure SEC source: 0001194416-04-000009 · c0001194416d20040519f4f.xml · nonDerivative · entry 7 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,827 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed May 19, 2004 22:15 UTC	CVS HEALTH Corp CVS · Entity 2884	Exercise / conversionCommon Stock	197,100	$16.72	$3,295,965.33	Disclosure SEC source: 0001194416-04-000009 · c0001194416d20040519f4f.xml · nonDerivative · entry 6 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,227 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed Jan 7, 2005 21:20 UTC	CVS HEALTH Corp CVS · Entity 2884	Exercise / conversionStock Option · Derivative	197,100	$0.00 Strike: $16.72	$0.00	Disclosure SEC source: 0001194405-05-000005 · c0001194416d20040519f4f.xml · derivative · entry 23 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,920 Underlying: Common Stock · 197,100 shares Expires 2006-04-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 19, 2004 Filed Jan 7, 2005 21:20 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	7,800	$40.25	$313,950.00	Disclosure SEC source: 0001194405-05-000005 · c0001194416d20040519f4f.xml · nonDerivative · entry 17 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,127 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed Jan 7, 2005 21:20 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	4,600	$40.24	$185,104.00	Disclosure SEC source: 0001194405-05-000005 · c0001194416d20040519f4f.xml · nonDerivative · entry 16 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,927 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed Jan 7, 2005 21:20 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	6,600	$40.23	$265,518.00	Disclosure SEC source: 0001194405-05-000005 · c0001194416d20040519f4f.xml · nonDerivative · entry 15 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,527 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed Jan 7, 2005 21:20 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	5,800	$40.22	$233,276.00	Disclosure SEC source: 0001194405-05-000005 · c0001194416d20040519f4f.xml · nonDerivative · entry 14 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,127 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed Jan 7, 2005 21:20 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	500	$40.21	$20,105.00	Disclosure SEC source: 0001194405-05-000005 · c0001194416d20040519f4f.xml · nonDerivative · entry 13 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,927 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed Jan 7, 2005 21:20 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	4,600	$40.20	$184,920.00	Disclosure SEC source: 0001194405-05-000005 · c0001194416d20040519f4f.xml · nonDerivative · entry 12 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,427 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed Jan 7, 2005 21:20 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	5,700	$40.19	$229,083.00	Disclosure SEC source: 0001194405-05-000005 · c0001194416d20040519f4f.xml · nonDerivative · entry 11 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,027 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed Jan 7, 2005 21:20 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	25,700	$40.18	$1,032,626.00	Disclosure SEC source: 0001194405-05-000005 · c0001194416d20040519f4f.xml · nonDerivative · entry 10 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,727 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed Jan 7, 2005 21:20 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	52,600	$40.17	$2,112,942.00	Disclosure SEC source: 0001194405-05-000005 · c0001194416d20040519f4f.xml · nonDerivative · entry 9 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,427 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed Jan 7, 2005 21:20 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	42,800	$40.16	$1,718,848.00	Disclosure SEC source: 0001194405-05-000005 · c0001194416d20040519f4f.xml · nonDerivative · entry 8 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,027 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed Jan 7, 2005 21:20 UTC	CVS HEALTH Corp CVS · Entity 2884	SaleCommon Stock	40,400	$40.15	$1,622,060.00	Disclosure SEC source: 0001194405-05-000005 · c0001194416d20040519f4f.xml · nonDerivative · entry 7 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,827 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 19, 2004 Filed Jan 7, 2005 21:20 UTC	CVS HEALTH Corp CVS · Entity 2884	Exercise / conversionCommon Stock	197,100	$16.72	$3,295,965.33	Disclosure SEC source: 0001194405-05-000005 · c0001194416d20040519f4f.xml · nonDerivative · entry 6 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,227 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document
May 18, 2004 Filed May 19, 2004 22:15 UTC	CVS HEALTH Corp CVS · Entity 2884	Exercise / conversionStock Option · Derivative	2,900	$0.00 Strike: $16.72	$0.00	Disclosure SEC source: 0001194416-04-000009 · c0001194416d20040519f4f.xml · derivative · entry 22 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,020 Underlying: Common Stock · 2,900 shares Expires 2006-04-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 18, 2004 Filed May 19, 2004 22:15 UTC	CVS HEALTH Corp CVS · Entity 2884	Exercise / conversionStock Option · Derivative	123,230	$0.00 Strike: $16.18	$0.00	Disclosure SEC source: 0001194416-04-000009 · c0001194416d20040519f4f.xml · derivative · entry 21 RYAN THOMAS M · CIK 0001194416 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 123,230 shares Expires 2005-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.